Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06051123
What this trial is testing

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Who this might be right for
ALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableActive Not RecruitingNCT03578796
What this trial is testing

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

Who this might be right for
Amyotrophic Lateral SclerosisCognitive Impairment
Haukeland University Hospital 31
Not applicableLooking for participantsNCT06249412
What this trial is testing

The Importance of Positive Expiratory Pressure Associated With the In-exsufflator in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis ALS7
Groupe Hospitalier du Havre 11
Not applicableStudy completedNCT03683875
What this trial is testing

Ultrasonography of the Neuromuscular Degeneration Behavior in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Hospital General Universitario Santa Lucia 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT07174492
What this trial is testing

Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
AB Science 412
Early research (Phase 1)Study completedNCT05795907
What this trial is testing

Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants

Who this might be right for
Amyotrophic Lateral Sclerosis (Healthy Volunteers)
Sanofi 84
Early research (Phase 1)WithdrawnNCT02242071
What this trial is testing

Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Neurogen Brain and Spine Institute
Early research (Phase 1)Study completedNCT05006352
What this trial is testing

Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Denali Therapeutics Inc. 29
Very early researchStudy completedNCT02710162
What this trial is testing

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Florida 21
Not applicableTemporarily pausedNCT03449212
What this trial is testing

SOD1 Kinetics Measurements in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis, FamilialAmyotrophic Lateral Sclerosis, Sporadic
Washington University School of Medicine 86
Not applicableStudy completedNCT03464903
What this trial is testing

Study of ALS Reversals 2: Genetic Analyses

Who this might be right for
Amyotrophic Lateral SclerosisProgressive Muscular Atrophy
Duke University 26
Early research (Phase 1)Study completedNCT01041222
What this trial is testing

Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations

Who this might be right for
Familial Amyotrophic Lateral Sclerosis
Ionis Pharmaceuticals, Inc. 33
Early research (Phase 1)Active Not RecruitingNCT05306457
What this trial is testing

CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Cedars-Sinai Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT03196375
What this trial is testing

Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

Who this might be right for
Motor Neuron Disease
Flex Pharma, Inc. 54
Not applicableTemporarily pausedNCT01959373
What this trial is testing

Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique Hopitaux De Marseille 30
Not applicableWithdrawnNCT00846560
What this trial is testing

Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Rambam Health Care Campus
Not applicableWithdrawnNCT06711510
What this trial is testing

Predict to Prevent PGRN Disease

Who this might be right for
Frontotemporal Dementia (FTD)GRN Related Frontotemporal Dementia
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT02469896
What this trial is testing

A Trial of Tocilizumab in ALS Subjects

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig's Disease+1 more
Barrow Neurological Institute 22
Not applicableLooking for participantsNCT06450691
What this trial is testing

Modeling Amyotrophic Lateral Sclerosis With Fibroblasts

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 110
Testing effectiveness (Phase 2)Study completedNCT01089010
What this trial is testing

CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 67
Next Page